In one phase 2 study: Pancreatitis was reported in about 0.4% of participants (1 out of 267) Gallbladder issues affected roughly 1.1%, with no cases in the placebo group Heart rhythm changes were reported more often in people taking retatrutide (about 6% compared to 3% with placebo) Liver enzyme increases were rare (around 1%), and overall liver health markers stayed stable over time
5 Additional in vitro and animal model research has examined GHK-Cu's effects on capillary cell recruitment, macrophage and mast cell activation markers, and collagen and elastin production in cultured and animal model systems
While the medication helps regulate appetite and blood sugar, daily routines reinforce these internal shifts and promote lasting progress
Seek urgent medical help (call NHS 111 or 999) if you develop severe persistent abdominal pain (which may indicate pancreatitis) or signs of a serious allergic reaction such as difficulty breathing, severe rash, or swelling of the face, lips or throat
Watch the full episode: www.youtube.com/watch?v=GGfrESBX0DQ #GLP1 #Podcast #Compliance #Semaglutide #Tirzepatide | Lengea Law